Zhang, J., Lei, J., You, C., Fu, W., Zheng, B., Cai, H., Liu, M., Li, N. (2025). Cost-effectiveness analysis of durvalumab with chemotherapy and maintenance durvalumab with or without olaparib for advanced endometrial cancer. Scientific Reports. https://doi.org/10.1038/s41598-025-86021-y